trending Market Intelligence /marketintelligence/en/news-insights/trending/CFr-CTUU9a9UdTPIZcuifQ2 content esgSubNav
In This List

Nektar Therapeutics exec joins AntriaBio board

Video

S&P Capital IQ Pro | Powering Your Edge

Video

S&P Capital IQ Pro | Unrivaled Sector Coverage

Blog

Enterprises are missing out on 24B by not optimizing cloud spending not going multicloud

Blog

Investment Research Analysts Providing Greater Coverage on Inflation


Nektar Therapeutics exec joins AntriaBio board

AntriaBio Inc. added Gil Labrucherie to its board.

Labrucherie is senior vice president and CFO of Nektar Therapeutics.